DUBLIN--ICON plc, (Nasdaq: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced today that it has completed a $40 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback